Dennis Matheis Net Worth

The estimated Net Worth of Dennis Matheis is at least $51.4 Mille dollars as of 18 August 2020. Mr. Matheis owns over 15,000 units of DarioHealth Corp stock worth over $51,350 and over the last 4 years he sold DRIO stock worth over $0. In addition, he makes $0 as Director at DarioHealth Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Matheis DRIO stock SEC Form 4 insiders trading

Dennis has made over 1 trades of the DarioHealth Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of DRIO stock worth $11,850 on 18 August 2020.

The largest trade he's ever made was buying 15,000 units of DarioHealth Corp stock on 18 August 2020 worth over $11,850. On average, Dennis trades about 3,000 units every 0 days since 2020. As of 18 August 2020 he still owns at least 65,000 units of DarioHealth Corp stock.

You can see the complete history of Mr. Matheis stock trades at the bottom of the page.

Dennis Matheis biography

Dennis Matheis serves as Director of the Company. Mr. Matheis spent nearly 30 years in various senior leadership roles in health insurance and healthcare. Since October 2017, he has served as the President and Chief Executive Officer of Optima Health, Inc., or Optima Health, and the Executive Vice President of Sentara Healthcare Plans, Inc., or Sentara Healthcare. Optima Health is the health plan division of Sentara Healthcare, provides health plan services and serves more than 500,000 members and consists of over 30,000 providers. Prior to joining Optima Health, he spent 13 years in leadership roles at Anthem, Inc., or Anthem. He served as President of Anthem's Central Region and Exchanges encompassing six states and representing $12 billion in annual revenue. Mr. Matheis also served in senior leadership roles at Anthem Blue Cross and Blue Shield of Missouri, CIGNA Healthcare and Humana Health Plan, as well as Advocate Health Care in Chicago. Mr. Matheis has a B.S. in Accounting from the University of Kentucky and practiced as a Certified Public Accountant before entering the healthcare industry.

What's Dennis Matheis's mailing address?

Dennis's mailing address filed with the SEC is 322 W 57TH ST, #33B, , NEW YORK, NY, 10019.

Insiders trading at DarioHealth Corp

Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern e Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.

What does DarioHealth Corp do?

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.

Complete history of Mr. Matheis stock trades at DarioHealth Corp

DarioHealth Corp executives and stock owners

DarioHealth Corp executives and other stock owners filed with the SEC include:

• Erez Raphael,
  Chief Executive Officer, Director
• Erez Raphael,
  CEO & Director
• Richard A. Anderson,
  Pres & GM of North America
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben-David,
  Chief Financial Officer, Treasurer, Secretary
• Olivier Jarry,
  Senior Vice President - Strategy and Business Development
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben David,
  CFO, Treasurer & Sec.
• Richard Stone,
  Independent Director
• Dennis McGrath,
  Independent Director
• Hila Karah,
  Independent Director
• Dennis Matheis,
  Director
• Omar Manejwala,
  Chief Medical Officer
• Barbara Stark,
  Senior Vice President, Head of Managed Markets
• Adam Stern,
  Director
• Yadin Shemmer,
  Independent Director
• Richard Anderson,
  President, General Manager - North America
• Allen Kamer,
  Independent Director
• Yoav Shaked,
  Independent Chairman of the Board
• Limor Drezner,
  VP HR & Chief of Staff
• Josh Fischer,
  Sr. VP of Operations & Compliance
• Yinon Amir,
  Head of Software Innovation
• Jean Christophe Muyl,
  Head of Commercialization North America
• Suzanne Bedell,
  VP of Marketing
• Claudia Levi,
  Content & Communications Mang.
• Dov Oppenheim,
  Co-Founder & Production Chief
• Olivier R. Jarry,
  Sr. VP of Strategy & Bus. Devel.
• Hod Rami Yehudiha,
  Director
• Glen Moller,
  Director
• Yalon Farhi,
  Director
• Malcolm Hoenlein,
  Director
• Ori Zanco,
  Director
• Yossi Bahagon,
  Director
• Shmuel Farhi,
  10% owner
• Yossef Balucka,
  CEO and President
• Oded Cohen,
  GM MSK
• Jon H. Kaplan,
  Director
• Tomer Ben Kiki,
  Chief Operating Officer
• Steven Charles Nelson,
  Chief Commercial Officer